Professor of Biostatistics in the Department of Medicine, HMS* Director of Biostatistics, Mass General Hospital Cancer Center

Dr. Finkelstein’s research is focused on the development of semi-parametric methodology for analyzing the effect of covariates on failure time distributions that arise in Cancer and Acquired Immune Deficiency Syndrome (AIDS) epidemiological studies and clinical trials. She has developed methods for analyzing the failure time distributions from interval censored data. Such interval censored data arise in screening studies, where the failure time is not known exactly, but rather is only known to lie in an interval which is of different length for each individual. Dr. Finkelstein’s research has also focused on the development of methods for analyzing longitudinal and survival outcomes, and on animal carcinogenicity experiments. Dr. Finkelstein is the director of Biostatistics at the MGH Cancer Center. In addition, she is the PI for the Statistical Coordinating Center for the Cancer Genetics Network, an NCI sponsored project to support research into the genetic basis of cancer susceptibility.

Ph.D., 1981, University of Michigan